Immunopharmacology of the hypoxanthine containing compounds isoprinosine and NPT 15392.
D000818:Animals; D000921:Antibody-Producing Cells / Q000187:drug effects; D001327:Autoimmune Diseases / Q000188:drug therapy; D006801:Humans; D007042:Hypoxanthines / Q000494:pharmacology*; D007109:Immunity / Q000187:drug effects*; D066298:In Vitro Techniques; D007239:Infections / Q000188:drug therapy; D007288:Inosine / Q000031:analogs & derivatives*; D007542:Inosine Pranobex / Q000494:pharmacology*; D007962:Leukocytes / Q000187:drug effects; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy; D013601:T-Lymphocytes / Q000187:drug effects
D007042:Hypoxanthines; D007288:Inosine; C026533:NPT 15392; D007542:Inosine Pranobex